Yongxin Zhang1, Yu Zhou1, Pengfei Yang1, Jianmin Liu1, Yi Xu1, Bo Hong1, Wenyuan Zhao1, Qi Chen2, Qing-Hai Huang3. 1. Department of Neurosurgery, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, People's Republic of China. 2. Department of Health Statistics, Second Military Medical University, 800 Xiangyin Road, Shanghai, 200433, People's Republic of China. 3. Department of Neurosurgery, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, People's Republic of China. ocinhqh@163.com.
Abstract
OBJECTIVES: The flow diverter (FD) is a device aimed at reconstructing the parent artery and occluding an aneurysm. We performed a propensity score-matched analysis to compare safety and efficacy between the FD and stent-assisted coiling. METHODS: A database review was conducted to identify patients with large and giant unruptured aneurysms (aneurysms located in the ACA, MCA, or PCA were excluded) treated with the FD or stent-assisted coiling. A propensity score, representing the probability of using the FD, was generated for each aneurysm using the relevant patient and aneurysmal variables. Angiographic results, complications, and clinical outcomes were compared. RESULTS: Forty-five aneurysms treated with the FD (FD alone: 32; FD+Coils: 13) and 45 treated with stent-assisted coiling were matched. The rate of complete occlusion was significantly (P = 0.0002) higher in the FD cohort than the conventional stent cohort at the 6-month follow-up. The FD cohort achieved greater improvement (P < 0.0001) and a lower rate of recurrence (P = 0.0001). The rate of periprocedural complications was similar, as was the proportion of patients who attained mRS ≤ 2 at discharge and at the 6-month follow-up. CONCLUSIONS: Our findings provide reliable evidence demonstrating that the FD may be a preferred treatment option for large and giant unruptured aneurysms. KEY POINTS: • Flow Diverter provided a higher complete occlusion rate at 6-month follow-up. • Flow Diverter achieved more progress occlusion and less recurrence. • Compared with the conventional stents, procedure-related morbidity of Flow Diverter was similar. • Flow Diverter is a preferred treatment for large and giant unruptured aneurysms.
OBJECTIVES: The flow diverter (FD) is a device aimed at reconstructing the parent artery and occluding an aneurysm. We performed a propensity score-matched analysis to compare safety and efficacy between the FD and stent-assisted coiling. METHODS: A database review was conducted to identify patients with large and giant unruptured aneurysms (aneurysms located in the ACA, MCA, or PCA were excluded) treated with the FD or stent-assisted coiling. A propensity score, representing the probability of using the FD, was generated for each aneurysm using the relevant patient and aneurysmal variables. Angiographic results, complications, and clinical outcomes were compared. RESULTS: Forty-five aneurysms treated with the FD (FD alone: 32; FD+Coils: 13) and 45 treated with stent-assisted coiling were matched. The rate of complete occlusion was significantly (P = 0.0002) higher in the FD cohort than the conventional stent cohort at the 6-month follow-up. The FD cohort achieved greater improvement (P < 0.0001) and a lower rate of recurrence (P = 0.0001). The rate of periprocedural complications was similar, as was the proportion of patients who attained mRS ≤ 2 at discharge and at the 6-month follow-up. CONCLUSIONS: Our findings provide reliable evidence demonstrating that the FD may be a preferred treatment option for large and giant unruptured aneurysms. KEY POINTS: • Flow Diverter provided a higher complete occlusion rate at 6-month follow-up. • Flow Diverter achieved more progress occlusion and less recurrence. • Compared with the conventional stents, procedure-related morbidity of Flow Diverter was similar. • Flow Diverter is a preferred treatment for large and giant unruptured aneurysms.
Authors: Santosh B Murthy; Shreyansh Shah; Aditi Shastri; Chethan P Venkatasubba Rao; Eric M Bershad; Jose I Suarez Journal: J Clin Neurosci Date: 2013-10-13 Impact factor: 1.961
Authors: Jennifer S McDonald; Robert J McDonald; Jiaquan Fan; David F Kallmes; Giuseppe Lanzino; Harry J Cloft Journal: Stroke Date: 2013-02-28 Impact factor: 7.914
Authors: Mario Zanaty; Nohra Chalouhi; Robert M Starke; Guilherme Barros; Mark Philip Saigh; Eric Winthrop Schwartz; Norman Ajiboye; Stavropoula I Tjoumakaris; David Hasan; Robert H Rosenwasser; Pascal Jabbour Journal: Stroke Date: 2014-07-22 Impact factor: 7.914
Authors: Ryan A McTaggart; Omar A Choudhri; Mary L Marcellus; Tom Brennan; Gary K Steinberg; Robert L Dodd; Huy M Do; Michael P Marks Journal: J Neurointerv Surg Date: 2014-04-16 Impact factor: 5.836
Authors: Qiaowei Wu; Tianxiao Li; Weijian Jiang; Juha Antero Hernesniemi; Li Li; Yingkun He Journal: Oxid Med Cell Longev Date: 2022-06-20 Impact factor: 7.310